“Tumor-infiltrating Myeloid Cells Contribute to Treatment Failure in Prostate Cancer”

Thursday, November 29, 2012
12:00 pm - 1:00 pm, Health Sciences Ctr. - Room 73-105

Lily Wu, Ph.D.

See below for additional information.


Free and open to the public.


Jonsson Comprehensive Cancer Center
(310) 825-5268

Additional Information

Presented by: Lily Wu, Ph.D., Professor, Department of Molecular & Medical Pharmacology

Dr. Lily Wu's research is aimed at developing a better understanding of cancer biology and improving gene-based therapy. She and her colleagues have utilized the efficient gene transfer property of adenovirus to create tissue-targeted therapy for cancer. By applying this targeted gene-expression approach to molecular imaging, metastatic lesions were detected in living tumor-bearing mice. To gain a better understanding of metastasis, the advanced and deadly stage of cancer, she and her colleagues are actively investigating tumor blood and lymphatic vasculatures that serve as routes of tumor cell spread. A variety of therapeutic approaches are being implemented in prostate and breast cancer models. In one strategy, they are modifying adenovirus and herpes virus to mediate cancer-specific lysis. Molecular imaging techniques such as optical charge-coupled devices (CCD) imaging and positron emission tomography (PET) are fundamental tools of their investigation. Wu's ultimate goal is to create potent and effective cancer-targeted therapy to diagnose and treat advanced stage and metastatic cancer.

*Light lunch served.

Search by Date

← Prev Week | Next Week →

View: Today | This Week | This Month

Homelessness in L.A has surged 75% in six years. Learn More. 100 Years. Knowledge Solves. UCLA.